Boston Therapeutics, Inc.
BTHEOTCHealthcare
$0.01
+$0.00(+0.00%)
Market Cap$0
P/E Ratio—
52W High$0.0119
52W Low$0.0091
Boston Therapeutics, Inc. (BTHE) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · BTHE · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2020-12 | 2019-12 | 2018-12 | 2017-12 | 2016-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.01M | $0.02M | $0.03M | $0.03M | $0.10M |
| Cost of Revenue | $0.03M | $0.03M | $0.07M | $0.00M | $0.09M |
| Gross Profit | ($0.02M) | ($0.01M) | ($0.04M) | $0.03M | $0.00M |
| Gross Margin %(computed) | -243.20% | -65.40% | -111.62% | 100.00% | 4.78% |
| Operating Expenses | |||||
| R&D Expenses | $0.18M | $1.71M | $0.18M | $0.18M | $0.08M |
| G&A Expenses | $0.58M | $0.98M | $1.74M | $1.09M | $1.07M |
| Total Operating Expenses | $0.76M | $3.48M | $2.00M | $1.30M | $1.27M |
| Operating Income | ($0.79M) | ($3.49M) | ($2.03M) | ($1.27M) | ($1.26M) |
| Operating Margin %(computed) | — | — | — | — | — |
| Interest Income | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Interest Expense | $0.43M | $0.34M | $0.73M | $1.66M | $1.94M |
| Income Before Tax | ($0.91M) | ($3.69M) | ($3.60M) | ($1.58M) | ($3.73M) |
| Income Tax Expense | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Net Income | ($0.91M) | ($3.69M) | ($3.60M) | ($1.58M) | ($3.74M) |
| Net Margin %(computed) | — | — | — | — | — |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-0.01 | $-0.04 | $-0.04 | $-0.03 | $-0.09 |
| Wtd Avg Shares | 111.13M | 102.50M | 102.50M | 51.47M | 43.54M |
| EBITDA | ($0.48M) | ($1.88M) | ($2.71M) | $0.14M | ($1.72M) |
| EBITDA Margin %(computed) | — | — | — | 471.70% | — |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · USD · M
Explore more Boston Therapeutics, Inc. data
About Boston Therapeutics, Inc. (BTHE) Income Statement
Boston Therapeutics, Inc. (BTHE) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2020, BTHE reported revenue of $0.00B, gross profit of ($0.00B) (gross margin -243.20%), and net income of ($0.00B) — a net profit margin of -9724.54%.
Frequently asked questions
BTHE · 4 questionsBoston Therapeutics, Inc. (BTHE) reported revenue of $0.00B for 2020, down 42.8% year-over-year.
BTHE revenueBTHE salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09